Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
MgupxBHBK0CkYDDK
Listen
